Furthermore, combining NK cells with SK‐BR‐3 cancer cells led to a significant upregulation of cytokines, explaining the molecular dynamics underlying NK cell activation in HER2‐positive breast cancer and highlighting their enhanced anticancer potential through complex cytokine‐mediated interactions. The gene discussed is ERBB2; the disease is breast cancer.